Efficacy of concurrent chemoradiotherapy with thalidomide and S-1 for esophageal carcinoma and its influence on serum tumor markers

BACKGROUND: Although the current conventional treatment strategies for esophageal carcinoma (EC) have been proven effective, they are often accompanied by serious adverse events. Therefore, it is still necessary to continue to explore new therapeutic strategies for EC to improve the clinical outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Tian-Wei, Zhang, Peng, Nie, Dong, Che, Xin-Yu, Fu, Tian-Tai, Zhang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401474/
https://www.ncbi.nlm.nih.gov/pubmed/37546558
http://dx.doi.org/10.4251/wjgo.v15.i7.1262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401474/
https://www.ncbi.nlm.nih.gov/pubmed/37546558
http://dx.doi.org/10.4251/wjgo.v15.i7.1262

Ejemplares similares